MAGNIN, A., V. C. IVERSEN, G. CALVO, B. CECETKOVA, O. DALE, Regina DEMLOVÁ, G. BLASKO, F. KEANE, G. L. KOVACS, C. LEVY-MARCHAL, E. C. MONTEIRO, L. PALMISANO, D. PELLA, A. P. PEREZ, O. RASCOL, C. SCHMID, F. TAY, H. VON DER LEYEN a C. OHMANN. European survey on national training activities in clinical research. CONTEMPORARY CLINICAL TRIALS. New York: Elsevier Science, 2019, roč. 20, č. 1, s. 1-9. ISSN 1551-7144. Dostupné z: https://dx.doi.org/10.1186/s13063-019-3702-z.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název European survey on national training activities in clinical research
Autoři MAGNIN, A., V. C. IVERSEN, G. CALVO, B. CECETKOVA, O. DALE, Regina DEMLOVÁ (203 Česká republika, domácí), G. BLASKO, F. KEANE, G. L. KOVACS, C. LEVY-MARCHAL, E. C. MONTEIRO, L. PALMISANO, D. PELLA, A. P. PEREZ, O. RASCOL, C. SCHMID, F. TAY, H. VON DER LEYEN a C. OHMANN.
Vydání CONTEMPORARY CLINICAL TRIALS, New York, Elsevier Science, 2019, 1551-7144.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30100 3.1 Basic medicine
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.832
Kód RIV RIV/00216224:14110/19:00116835
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1186/s13063-019-3702-z
UT WoS 000502747300003
Klíčová slova anglicky Clinical research; Clinical study; Clinical trial; Survey; Training; GCP-training; ECRIN; Career options; Training requirements; Clinical study personnel
Štítky 14110516, Excelence Science, INT, MU, RIV, rivok, user
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 12. 5. 2021 14:11.
Anotace
Background: Investigator-initiated clinical studies (IITs) are crucial to generate reliable evidence that answers questions of day-to-day clinical practice. Many challenges make IITs a complex endeavour, for example, IITs often need to be multinational in order to recruit a sufficient number of patients. Recent studies highlighted that well-trained study personnel are a major factor to conduct such complex IITs successfully. As of today, however, no overview of the European training activities, requirements and career options for clinical study personnel exists. Methods: To fill this knowledge gap, a survey was performed in all 11 member and observer countries of the European Clinical Research Infrastructure Network (ECRIN), using a standardised questionnaire. Three rounds of data collection were performed to maximize completeness and comparability of the received answers. The survey aimed to describe the landscape of academic training opportunities, to facilitate the exchange of expertise and experience among countries and to identify new fields of action. Results: The survey found that training for Good Clinical Practice (GCP) and investigator training is offered in all but one country. A specific training for study nurses or study coordinators is also either provided or planned in ten out of eleven countries. A majority of countries train in monitoring and clinical pharmacovigilance and offer specific training for principal investigators but only few countries also train operators of clinical research organisations (CRO) or provide training for methodology and quality management systems (QMS). Minimal requirements for study-specific functions cover GCP in ten countries. Only three countries issued no requirements or recommendations regarding the continuous training of study personnel. Yet, only four countries developed a national strategy for training in clinical research and the career options for clinical researchers are still limited in the majority of countries. Conclusions: There is a substantial and impressive investment in training and education of clinical research in the individual ECRIN countries. But so far, a systematic approach for (top-down) strategic and overarching considerations and cross-network exchange is missing. Exchange of available curricula and sets of core competencies between countries could be a starting point for improving the situation.
Návaznosti
CZ.02.1.01/0.0/0.0/16_013/0001826, interní kód MU
(Kód CEP: EF16_013/0001826)
Název: CZECRIN_PRO PACIENTY - zavádění inovativních moderních terapií
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CZECRIN_PRO PACIENTY - zavádění inovativních moderních terapií, PO 1 Posilování kapacit pro kvalitní výzkum
LM2015090, projekt VaVNázev: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu
VytisknoutZobrazeno: 24. 4. 2024 15:40